Efficacy and specificity of non-steroidal anti-inflammatory drugs for the inhibition of cytokine-stimulated prostaglandin E2 secretion by amnion-derived WISH cells

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 66, Issue 5-6, 2002, Pages 525-527

  Sato, T A ^a   Keelan, J A ^a   Blumenstein, M ^a   Mitchell, M D ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

3 (3 FLUOROPHENYL) 5,5 DIMETHYL 4 (4 METHYLSULFONYLPHENYL) 2(5H) FURANONE; ARACHIDONYL TRIFLUOROMETHYL KETONE; ETODOLAC; INDOMETACIN; INTERLEUKIN 1BETA; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

AMNION; ARTICLE; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; DRUG SPECIFICITY; HUMAN; HUMAN CELL; IC 50; INHIBITION KINETICS; PREMATURE LABOR; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; RADIOIMMUNOASSAY;

EID: 0036586637     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1054/plef.2002.0394     Document Type: Article

References (25)

1. Arntzen K. J., Kjollesdal A. M., Halgunset J., Vatten L., Austgulen R. TNF, IL-1, IL-6, IL-8 and soluble TNF receptors in relation to chorioamnionitis and premature labor. J Perinat Med 1998; 26: 17-26.
2. Romero R., Wu Y. K., Brody D. T., Duff G. W., Durum S. K. Human decidua: a source of interleukin-1. Obstet Gynecol 1989; 73: 31-34.
3. Mitchell M. D., Romero R. J., Edwin S. S., Trautman M. S. Prostaglandins and parturition. Reprod Fertil Dev 1995; 7: 623-632.
4. Romero R., Mazor M., Tartakovsky B. Systemic administration of interleukin-1 induces preterm parturition in mice. Am J Obstet Gynecol 1991; 165: 969-971.
5. Funk C. D. Molecular biology in the eicosanoid field. Nucleic Acids Res 1993; 45: 67-98.
6. Kawaguchi H., Yarari R., Stover M. L., Rowe D. W., Raisz L. G., Pilbeam C. C. Measurement of IL-1 stimulated constitutive prostaglandin G/H synthase (cyclooxygenase) mRNA levels in osteoblastic MC3T3-E1 cells using competitive reverse transcriptase polymerase chain reaction. Endocrinol Res 1994; 20: 219-233.
7. Mitchell J. A., Larkin S., Williams T. J. Cyclooxygenase-2: regulation and relevance in inflammation. Biochem Pharmacol 1995; 50: 1535-1542.
8. Freed K. A., Aitken M. A., Brennecke S. P., Rice G. E. Prostaglandin G/H synthase-1 messenger RNA realtive abundance in human amnion, choriodecidua and placenta before, during and after spontaneous-onset labour at term. Gynecol Obstet Invest 1995; 39: 73-78.
9. Fuentes A., Spaziani E. P., O'Brien W. F. The expression of cyclooxygenase-2 (COX-2) in amnion and decidua following spontaneous labor. Prostaglandins 1996; 52: 261-267.
10. Gibb W. The role of prostaglandins in human parturition. Ann Med 1998; 30: 235-241.
11. Mijovic J. E., Zakar T., Nairn T. K., Olson D. M. Prostaglandin endoperoxide H synthase (PGHS) activity and PGHS-1 and -2 messenger ribonucleic acid abundance in human chorion throughout gestation and with preterm labor. J Clin Endocrinol Metab 1998; 83: 1358-1367.
12. Hansen W. R., Keelan J. A., Skinner S. J., Mitchell M. D. Key enzymes of prostaglandin biosynthesis and metabolism. Coordinate regulation of expression by cytokines in gestational tissues: a review. Prostaglandins 1999; 57: 243-257.
13. Vane J. R., Botting R. M. New insights into the mode of action of anti-inflammatory drugs. Inflamm Res 1995; 44: 1-10.
14. Hayllar J., Bjarnason I. NSAIDs, Cox-2 inhibitors, and the gut. Lancet 1995; 346: 521-522.
15. Murray M. D., Brater D. C. Renal toxicitiy of the nonsteroidal anti-inflammatory drugs. Ann Rev Toxicol 1993; 32: 435-465.
16. Bivins H. A. Jr., Newman R. B., Fyfe D. A., Campbell B. A., Stramm S. L. Randomized trial of oral indomethacin and terbutaline sulfate for the long long-term suppression of preterm labor. Am J Obstet Gynecol 1993; 169: 1065-1070.
17. Morrison J. C., Albert J. R., Floyd R. C., Bale C. S., Lou C. H., Gookin K. S. Interval to delivery in high-risk patients do tocolytic agents really work? Int J Gynecol Obstet 1992; 38: 189-193.
18. Mittendorf R., Pryde P., Khoshnood B., Lee K. S. If tocolytic magnesium sulfate is associated with excess total pediatric mortality, what is its impact? Obstetr Gynecol 1998; 92: 308-311.
19. Salokorpi T., Eronen M., Von Wendt L. Growth and development until 18 months of children exposed to tocolytics indomethacin or nylidrin. Neuropediatrics 1996; 27: 174-177.
20. Perry Jr K. G., Morrison J. C., Rust O. A., Sullivan C. A., Martin R. W., Naef R. W. Incidence of adverse cardiopulmonary effect with low-dose continuous terbutaline infusion. Am J Obstet Gynecol 1995; 173: 1273-1277.
21. Donnelly M. T., Hawkey C. J. Review article: COX-II inhibitors - a new generation of safer NSAIDs? Aliment Pharmacol Ther 1997; 11: 227-236.
22. Riendeau D., Percival M. D., Boyce S., Brideau C., Charleson S., Cromlish W., et al: Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Br J Pharmacol 1997; 121: 105-117.
23. Keelan J. A., Sato T. A., Hansen W. R., Gilmour J. S., Gupta D. K., Helsby N. A., Mitchell M. D. Interleukin-4 differentially regulates prostaglandin production in amnion-derived WISH cells stimulated with pro-inflammatory cytokines and epidermal growth factor. Prostaglandins Leukot Essent Fatty Acids 1999; 60: 255-262.
24. Simpson K. L., Keelan J. A., Mitchell M. D. Labor-associated changes in interleukin-10 production and its regulation by immunomodulators in human choriodecidua. J Clin Endocrinol Metab 1998; 83: 4332-4337.
25. Grigsby P., Poore K., Hirst J., Jenkin G. Inhibition of premature labor in sheep by a combination treatment of nimesulide, a prostaglandin synthase type 2 inhibitor, and atosiban, an oxytocin receptor antagonist. Am J Obstet Gynecol 2000; 183: 649-657.